Endocannabinoid and nitric oxide interaction mediates food intake in neonatal chicken.

1. The aim of the current study was to investigate the interaction of the nitric oxide and cannabinoidergic systems on feeding behaviour in neonatal chicken. 2. A total of 6 experiments were designed to evaluate the interaction between cannabinoidergic and nitrergic systems on food intake in 3-h food-deprived (FD3) neonatal chickens. In Experiment 1, chickens received intracerebroventricular (ICV) injections of saline, 2-AG (a CB1 receptor agonist, 2µg), L-arginine (nitric oxide precursor, 200 nmol) and co-administration of 2-AG+L-arginine. In Experiment 2, ICV injection of saline, 2-AG (2µg), L-NAME (a nitric oxide synthesis inhibitor, 100 nmol) and their combination (2-AG+L-NAME) were applied to the birds. In Experiment 3, injections were saline, CB65 (a CB2 receptor agonist, 1.25 µg), L-arginine (200 nmol) and CB65+L-arginine. In Experiment 4, birds received ICV injection of saline, CB65 (1.25 µg), L-NAME (100 nmol) and CB65+L-NAME. In Experiment 5, chickens were ICV injected with saline, L-arginine (800 nmol), SR141716A (a selective CB1 receptor antagonist, 6.25 µg) and L-arginine+SR141716A. In Experiment 6, birds were injected with saline, L-arginine (800 nmol), AM630 (a selective CB2 receptor antagonist, 5 µg) and L-arginine+AM630. Cumulative food intake was recorded until 2-h post injection. 3. ICV injection of CB1 and CB2receptor agonists increased food intake. Co-injection of 2-AG+L-NAME increased the hyperphagic effects of CB1 receptors. CB2 receptor induced food intake was not affected by co-administration of CB65+L-NAME. L-arginine decreased food intake and this effect was amplified by co-injection of L-arginine+SR141716A. However; CB2 receptor antagonists had no effect on L-arginine-induced hypophagia. 4. The results suggest that there is an interaction between endogenous nitric oxide and the cannabinoidergic system on feeding behaviour which is mediated via CB1 receptors in the neonatal chicken.